Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Debt Ratio (2016 - 2025)

Historic Debt Ratio for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 0.35.

  • BioRestorative Therapies' Debt Ratio rose 4711.65% to 0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35, marking a year-over-year increase of 4711.65%. This contributed to the annual value of 0.21 for FY2024, which is 110.96% down from last year.
  • According to the latest figures from Q3 2025, BioRestorative Therapies' Debt Ratio is 0.35, which was up 4711.65% from 0.3 recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Debt Ratio high stood at 2.71 for Q3 2021, and its period low was 0.01 during Q4 2021.
  • Over the past 5 years, BioRestorative Therapies' median Debt Ratio value was 0.33 (recorded in 2022), while the average stood at 0.57.
  • Its Debt Ratio has fluctuated over the past 5 years, first plummeted by 9859.92% in 2021, then skyrocketed by 235047.76% in 2022.
  • Over the past 5 years, BioRestorative Therapies' Debt Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 2350.48% to 0.34 in 2022, then crashed by 38.44% to 0.21 in 2023, then dropped by 1.11% to 0.21 in 2024, then skyrocketed by 69.92% to 0.35 in 2025.
  • Its last three reported values are 0.35 in Q3 2025, 0.3 for Q2 2025, and 0.31 during Q1 2025.